Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Headache and Facial Pain

Harvard Medical School, Beth Israel Deaconess Medical Center and Harvard School of Dental Medicine
Headache and Facial Pain program provides new techniques and discoveries that are frequently being introduced to clinicians at the basic science level. This program will offer generalists and specialists a state-of-the-art perspective in scientific inquiry and clinical practice, relevant to the application of pain medicine to headache and facial pain.
 
CREDITS Earn up to 19.75 AMA PRA Category 1 Credits
CE RELEASE August 1, 2008
CE EXPIRE July 31, 2010
 
Item No Media (Can't decide on a format?) Price Purchase
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Kyle Jackson at 1-800-952-0690 x3075.
 

Topics & Speakers


  • Clinical Evaluation and Diagnostic
    Criteria for Head Neck and Face Pain
  • Acute and Preventive
    Treatment of Headache
  • Facial Pain, PHN, and TGN
  • Risk Reduction in Headache and
    Pain Medicine
  • Botulinum Toxins and Neurolytic Blocks
    for Head, Neck, and Face Pain
  • Inpatient Treatment of Refractory Headache
    Zahid Bajwa, MD

  • Migraine, PFO, and Stroke
    Louis Caplan, MD

  • The Multidisciplinary Approach:
    When Two Heads Really Are Better
  • Relax! Psychological Intervention
    for Headache Management
  • Risky Business:Managing the
    Difficulty with Difficult Patients
  • Treatment Failure: What to Say
    When There’s Nothing Left to Do

    Joshua Wootton, MDiv, PhD

  • Dentist’s Role in the Management
    of Headache and Cervical Pain

    Noshir Mehta, DMD, MS, FICD

  • Keynote Lecture: Scientific Rationale
    for Choosing Migraine Therapy

    Rami Burstein, PhD
  • Acupuncture and Herbal Therapies
    in Headache and Facial Pain

    Joseph Audette, MA, MD

  • Headache in Children and Adolescents
    Alyssa Lebel, MD

  • Management of Chronic Daily Headaches
    Egilius Spierings, MD, PhD
  • Cervicogenic and Post-Traumatic Headaches
  • Opioids and Combination Analgesics
    David Biondi, DO

  • Historical Milestones in Understanding
    Migraine Mechanisms and Therapy

    Egilius Spierings, MD, PhD

  • Medicolegal Case Discussions
    Drs. Bajwa, Biondi, Brian McGeeney, MD,
    Spierings and Wootton


  • Advanced Therapies for Intractable Head
    and Neck Pain

    Thomas Simopoulous, MD

  • Headache and Pain Boards with Q&A
    Drs. McGeeney and Steven Scrivani, DMD, DMedSc

  • Headache and Pain Boards
    with Interesting Cases

    Drs. Bajwa, McGeeney, Scrivani and Spierings



Faculty

Harvard Medical School Course Directors

Zahid Bajwa, MD
Joshua Wootton, MDiv, PhD


Harvard Medical School Course Faculty
Beth Israel Deaconess Medical Center
Zahid Bajwa, MD
Rami Burstein, PhD
Carolyn DeBeauport, RNP
Thomas Simopoulous, MD
Joshua Wootton, MDiv, PhD

Brigham and Women’s Hospital
Egilius Spierings, MD, PhD

Children’s Hospital
Alyssa Lebel, MD

Massachusetts General Hospital
Joseph Audette, MA, MD

Guest Faculty

David Biondi, DO
Director, Clinical Development
Ortho-McNeil Neurologics
Titusville, NJ


Louis Caplan, MD
Professor of Neurology,
Harvard Medical School
Boston, MA


Brian McGeeney, MD
Assistant Professor of Neurology
Boston University Medical School
Boston, MA

Noshir Mehta, DMD, MS, FICD
Professor and Chairman
General Dentistry
Tufts Dental School
Boston, MA


Steven Scrivani, DMD, DMedSc
Associate Professor
Tufts Dental School
Boston, MA

 
 

Learning Objectives


This program is designed for participants wishing to achieve competence and improve their skills in assessing headache and facial pain patients. It will incorporate a survey of the principal evidence-based treatments, including pharmacology, surgical procedures, psychology, and complementary medicine, and the methods examined will range from conservative and non-invasive to radical and invasive, with special attention to the comparative risks involved and their physical and psychosocial impact on the patient. Clinicians preparing for board exams will find this course helpful. 
 
 

Accreditation Statement


Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
 

Designation


Harvard Medical School designates this educational activity for a maximum of 19.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release date: August 1, 2008       Credits expire: July 31, 2010

CME credit is obtained upon successful completion of an activity posttest and evaluation, as well as payment of a $30 processing fee.
 
 

Disclosure


Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. Now, in accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers and their spouses/partners, and planners have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prosthesis, etc. that might be germane to the content of their lectures. Please note that now in accordance with recent policies from the ACCME, relationships of the person involved in the CME activity must include financial relationships of a spouse or partner.

In addition, faculty have been asked to describe any off label uses, they will discuss, of pharmaceuticals and devices for investigational or non-FDA approved purposes.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk. The full disclosure of faculty is listed in the syllabus.